Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-26

Clinical Trial Update: NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A completed Phase 4 randomized trial evaluated prophylaxis with N-acetylcysteine, sodium bicarbonate, and normal saline to prevent contrast-induced nephropathy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)
  • Normal Saline (sodium chloride 0.9% solution)
  • Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Karadeniz Technical University | Conditions: Radiographic Contrast Agent Nephropathy, Pulmonary Embolism | Phase 4 | Status: COMPLETED